Skip to main content

Estramustine Phosphate Therapy in Carcinoma of the Prostate

  • Chapter
Tumors of the Male Genital System

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 60))

Abstract

Estramustine phosphate in the treatment of prostatic carcinoma was introduced in 1966. The substance is an estradiol-17-β-phosphate which is esterified with nor nitrogen mustard as a carbamate. It has become known under the trade name Estracyt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Farnsworth, W.E.: Personal communication

    Google Scholar 

  2. Fredholm, B., Jensen, G., Lindskog, M., Müntzing, J.: Effects of estramustine phosphate (Estracyt®) on growth of DMBA-induced mammary tumours in rats. Acta pharmacol. (Kbh.) 35 (1974) (abstract)

    Google Scholar 

  3. Jönsson, G., Olsson, A.M., Luttropp, W., Cekan, Z., Purvis, K., Diczfalusy, E.: Treatment of prostatic carcinoma with various types of estrogen derivatives. II Steroid levels. Vitam. and Horm. 33, 351 (1975)

    Article  Google Scholar 

  4. Kirdani, R.Y., Müntzing, J., Verkarakis, M.J., Murphy, G.P., Sandberg, A.A.: Studies on the antiprostatic action of Estracyt, a nitrogen mustard of estradiol. Cancer Res. 34, 1031–1037 (1974)

    PubMed  CAS  Google Scholar 

  5. Mittelman, A., Shukla, S.K., Welwaart, K., Murphy, G.P.: Oral estramustine phosphate (NSC-89199) in the treatment of advanced (Stage D) carcinoma of the prostate. Cancer Chemother. Rep. Part 1, 59, 219–223 (1975)

    Google Scholar 

  6. Nillius, A., Könyves, I.: Oral Estracyt (estramustine phosphate) in the treatment of advanced carcinoma of the prostate. In press (1975)

    Google Scholar 

  7. Nilsson, T., Jönsson, G.: Clinical results with estramustine phosphate (NSC-89199): A comparison of the intravenous and oral preparations. Cancer Chemother. Rep. Part 1, 59, 229–232 (1975)

    Google Scholar 

  8. The Veterans Administration Cooperative Urological Research Group: Carcinoma of the prostate: A continuing co-operative study. J. Urol. (Baltimore) 91, 590–594 (1964)

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Andersson, L., Edsmyr, F., Jönsson, G., Könyves, I. (1977). Estramustine Phosphate Therapy in Carcinoma of the Prostate. In: Grundmann, E., Vahlensieck, W. (eds) Tumors of the Male Genital System. Recent Results in Cancer Research, vol 60. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81095-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81095-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81097-8

  • Online ISBN: 978-3-642-81095-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics